Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9122 |
High Similarity |
NPD4380 |
Phase 2 |
0.9067 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8912 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8889 |
High Similarity |
NPD7075 |
Discontinued |
0.8874 |
High Similarity |
NPD1934 |
Approved |
0.8819 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8819 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8816 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8766 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8759 |
High Similarity |
NPD1549 |
Phase 2 |
0.8758 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8627 |
High Similarity |
NPD6801 |
Discontinued |
0.8625 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD6166 |
Phase 2 |
0.8533 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8493 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8467 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8452 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8446 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8442 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8425 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8403 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8365 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8344 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8344 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8344 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8302 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8288 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8288 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8282 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8258 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8255 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8242 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8235 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8232 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8228 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8221 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.817 |
Intermediate Similarity |
NPD2532 |
Approved |
0.817 |
Intermediate Similarity |
NPD2534 |
Approved |
0.817 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8165 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8133 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8098 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8084 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8065 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8026 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7976 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7961 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7961 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7949 |
Intermediate Similarity |
NPD920 |
Approved |
0.7939 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7937 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7935 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7908 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7891 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7881 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7881 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7881 |
Intermediate Similarity |
NPD6099 |
Approved |
0.787 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.784 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7821 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7806 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7792 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7738 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7697 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7683 |
Intermediate Similarity |
NPD919 |
Approved |
0.7667 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7667 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7651 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7635 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7616 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7614 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7582 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.756 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7554 |
Intermediate Similarity |
NPD7584 |
Approved |
0.755 |
Intermediate Similarity |
NPD943 |
Approved |
0.7546 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7542 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8312 |
Approved |
0.75 |
Intermediate Similarity |
NPD2654 |
Approved |
0.75 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7467 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7466 |
Intermediate Similarity |
NPD9717 |
Approved |
0.745 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.744 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7421 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7407 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7405 |
Intermediate Similarity |
NPD2309 |
Approved |
0.74 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7397 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7396 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7389 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7386 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7372 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7372 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7372 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7322 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7322 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7322 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7322 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7322 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7322 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7322 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7303 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7303 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7288 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD37 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7262 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7246 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7244 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7241 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7239 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7237 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7229 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7228 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7204 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7196 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7178 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7161 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7161 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7135 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD8651 |
Approved |
0.712 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7114 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7112 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7112 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7112 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7111 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7105 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7093
|
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |